Department of Neurology, Chiba Rosai Hospital, Japan.
Department of Neurology, Graduate School of Medicine, Chiba University, Japan.
Intern Med. 2022 Oct 1;61(19):2957-2959. doi: 10.2169/internalmedicine.9781-22. Epub 2022 Jul 29.
Loss of taste is a relatively common symptom of coronavirus disease 2019 (COVID-19) and has also been considered a rare Guillain-Barré syndrome (GBS) symptom. We herein report a case of a facial diplegia and paresthesia (FDP) variant of GBS that initially presented as a loss of taste occurring two weeks after COVID-19 mRNA vaccination. The patient recovered completely after intravenous immunoglobulin therapy. Clinicians should consider the possibility of post-vaccination FDP manifesting as facial palsy and should be aware that GBS, including the FDP variant, can initially present as an isolated loss of taste.
失去味觉是 2019 冠状病毒病（COVID-19）的一个相对常见症状，也被认为是吉兰-巴雷综合征（GBS）的罕见症状。我们在此报告一例 FDP 变异型 GBS，最初表现为 COVID-19 mRNA 疫苗接种后两周出现味觉丧失。患者经静脉注射免疫球蛋白治疗后完全康复。临床医生应考虑 FDP 在接种疫苗后表现为面瘫的可能性，并应意识到包括 FDP 变异型在内的 GBS 最初可能表现为孤立性味觉丧失。
